Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring, today gives notice that its Annual Report and Accounts for the year ended 31 December 2017 has been published
Deltex Medical Group’s Ewan Phillips discusses their full year results, what’s been happening operationally, their strategy for the next 12 months and what investors should look forward to in the near future in this exclusive interview with DirectorsTalk
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), today announced that it will be hosting an investor event on 22 May 2018 following the publication
Deltex Medical Group (LON:DEMG) CEO Ewan Phillips talks to DirectorsTalk about its 2017 year end results. Ewan talks us through the highlights, explains whats been happening operationally this year, the
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), today announced the launch of the TrueVueTM Loops display software on its CardioQ-ODM+ haemodynamic monitoring platform. The TrueVueTM Loops
Nigel Keen, Chairman of Deltex Medical, commented: “The progress made towards operating cash breakeven and profitability through improved consumable margins and reduced overheads made during 2017 was partially offset by
Deltex Medical will be supporting a forthcoming congress in London on May 28th. Current Initiatives, Research and the Role of Hemodynamic Monitoring is free to attend for clinicians and healthcare providers who
It takes a plethora of products and people to provide patients premium protection. Changing payment models, the digitization of healthcare and the need to deliver higher quality care at a
Clinician-led disseminator of medical news, TopMedTalk has reviewed the landmark FEDORA study into Goal-Directed Haemodynamic Therapy (GDHT). Reinforcing the conclusions from meta-analysis of 70 other studies, FEDORA supports the use of Oesophageal
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), announced today that it intends to release its results for the year ended 31 December 2017 on
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
